Home » Diagnostics » Drug Discovery & Development

Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

MIT Drug-Discovery Spinout ReviveMed Raises $1.5M

ReviveMed's technology uses artificial intelligence-based analysis of metabolomics data for drug discovery and development.

Veracyte, Loxo Oncology Partner on Drug Development Research

Veracyte will use its Afirma assay to analyze thyroid cancers and inform Loxo's drug development pipeline for targeted therapies.

UCB Acquires Element Genomics for $30M

Element Genomics' technology will increase UCB's pipeline, focusing on target discovery and interpretation in disease relevant systems.

Exosome Diagnostics, Intezyne to Develop Exosomal RNA Assay for Novel CRP Inhibitor

The company will design and validate a test using its Exolution isolation kit, which can stratify and monitor patients in Intezyne's clinical trials of IT-139.

Nohla Therapeutics to Use Karius Pathogen Detection Test in AML Therapy Trial

Nohla will use Karius' NGS plasma test for pathogen detection in a randomized trial evaluating Nohla's lead product, a cellular therapy called NLA101.

Feb 12, 2018

Search of Soil Microbiome Turns Up New Class of Antibiotics Called Malacidins

Feb 09, 2018

Q-State Subsidiary Buys Claritas Assets, Plans Relaunch of Lab to Support Drug Discovery Programs

Premium
Feb 01, 2018

Publication Highlights Key Questions as Basket Studies Proliferate

Premium
Jan 31, 2018

Ambry Genetics, Invicro Partner to Combine Imaging, Genomics Services

Jan 31, 2018

Drug Discovery Startup Engine Biosciences Raises $10M

Jan 17, 2018

Quanterix Hopes IPO Will Help Drive Biotech, Pharma Business

Premium
Jan 16, 2018

Startup Datavant Foresees Pharma Success in Aggregating Genomic, Claims, EHR Data

Premium
Jan 10, 2018

Amgen Finland, BC Platforms Partner to Link Genomic Data, EMRs in Disease Studies

Premium
Jan 09, 2018

WuXi NextCode, Rhythm Pharmaceuticals Partner Around Rare Metabolic Syndromes

Jan 05, 2018

Analytics Startup Datavant Inks Partnerships with G3, Duke, Verge Genomics

Jan 04, 2018

Pfizer to Use Berkeley Lights' Single-Cell Tech to Streamline Workflows

Dec 19, 2017

Finnish Researchers, Pharma Partners to Genotype 500K Samples as Part of New €59M Study

Premium
Dec 13, 2017

Pairnomix Discusses Early Anecdotes From Patients Treated Using Individualized Drug Screen

Premium
Dec 13, 2017

X-Chem, Abilita Form Drug Discovery Partnership

Dec 06, 2017

Janssen to Evaluate Genomic Health GPS Test for Use in Prostate Cancer Drug Pipeline

Dec 04, 2017

Ncardia, Evotec Sign Licencing Agreement for iPS Cell Disease Modeling

Nov 28, 2017

Base Pair Biotechnologies Raises $3.2M

Nov 16, 2017

Regeneron Says Large-Scale Human Genetics Starting to Generate New Drug Targets

Premium
Nov 16, 2017

Guardant Health, Bristol-Myers Squibb to Deploy Liquid Biopsies in Clinical Trials

Oct 31, 2017

DoD Awards $10M to Consortium to ID New TB Drug Targets

More articles

The Scan

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

May
15
Featured Webinar

Reaping the Benefits of Algorithm-Driven Research in Synthetic Biology

Sponsored by
Tecan

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.

What's Popular?

In Drug Discovery & Development

  1. MIT Drug-Discovery Spinout ReviveMed Raises $1.5M

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.